Five studies showed a 100% concordance of KRAS mutation status in primary CRC and corresponding metastases (Losi et al, 1992; Suchy et al, 1992; Zauber et al, 2003; Weber et al, 2007; Etienne-Grimaldi et al, 2008). This evidence concerns the gene KRAS and colorectal carcinoma.